GLP Watchdog

EverPrime vs Gala

Neither EverPrime nor Gala has an FDA warning letter on record. On compounded semaglutide injection, Gala costs $1,089 less a year at standing rates: $179 a month against $249 a month (billed every 4 weeks) at EverPrime. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

EverPrime / Gala

EverPrime logo

EverPrime

7.5/10

Featured pick (affiliate partner)

Gala logo

Gala

8.5/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$169/moCompounded tirzepatide injection
$179/moCompounded semaglutide injection
States
40 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit EverPrime
Visit Gala

Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. EverPrime pays us nothing. The scores are computed the same way for both and are shown as computed (EverPrime 7.5, Gala 8.5). How we are paid

What the record shows

  1. 01

    Neither EverPrime nor Gala has an FDA warning letter on record.

  2. 02

    EverPrime names five pharmacies. Gala names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Gala costs $1,089 less a year at standing rates: $179 a month against $249 a month (billed every 4 weeks) at EverPrime. It is one of two products the two sell at comparable terms.

  4. 04

    Only Gala lists a price for brand-name semaglutide pen.

  5. 05

    Gala covers 10 states EverPrime does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

EverPrime

Gala

Compounded semaglutide injection

$249/mo

$3,237 a year, 13 charges

$179/moLower

$2,148 a year

Compounded tirzepatide injection

$169/moLower

$2,028 a year

$179/mo

$2,148 a year

Brand-name semaglutide pen
Not sold or not priced

$1,299/mo

$15,588 a year

Price includes
Medication, clinician visits, shipping, labs
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the 1-month plan; 3-, 6- and 12-month plans are paid upfront
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
Refunds
Full refund if your provider decides treatment isn't right for you. No refund once the pharmacy starts preparing an order; prepaid plan and membership payments are non-refundable; no returns on prescription products.
No refund on cancellation; full refund only if the medical provider disqualifies you

Read off each seller’s own pages. EverPrime: October 27, 2026. Gala: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for EverPrime

7.5/10
  • $120 a year less on compounded tirzepatide injection
  • Names its compounding pharmacy
Visit EverPrime

The case for Gala

8.5/10
Featured pick (affiliate partner)
  • $1,089 a year less on compounded semaglutide injection
  • Sells brand-name semaglutide pen, which EverPrime does not price
  • Lists 50 states against 40
  • Names no compounding pharmacy
Visit Gala

Scores

EverPrime 7.5 · Gala 8.5 out of 10. Six weighted parts.

Value25%

3.5A
vs
B
7.9

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

7.5A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
7.5

Accessibility10%

8.4A
vs
B
10.0

Support10%

8.5A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

EverPrime vs Gala: questions

Neither EverPrime nor Gala has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
EverPrime names five pharmacies. Gala names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Gala, by $1,089 a year at standing rates. EverPrime: $249 a month (billed every 4 weeks), about $3,237 a year. Gala: $179 a month, about $2,148 a year.
EverPrime states you can cancel at any time; refunds: full refund if your provider decides treatment isn't right for you. no refund once the pharmacy starts preparing an order; prepaid plan and membership payments are non-refundable; no returns on prescription products. Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you.
Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. EverPrime pays us nothing. The scores are computed the same way for both and are shown as computed (EverPrime 7.5, Gala 8.5).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks